The Journal of Pain / Apr 01, 2015

Tennant, F., Bilello, J., & Thurmond, L. (2015). (132) Use of a depression biomarker panel to diagnose depression in chronic pain patients. The Journal of Pain, 16(4), S9. https://doi.org/10.1016/j.jpain.2015.01.046

The Journal of Clinical Psychiatry / Feb 25, 2015

Bilello, J. A., Thurmond, L. M., Smith, K. M., Pi, B., Rubin, R., Wright, S. M., Taub, F., Henry, M. E., Shelton, R. C., & Papakostas, G. I. (2015). MDDScore: Confirmation of a Blood Test to Aid in the Diagnosis of Major Depressive Disorder. The Journal of Clinical Psychiatry, 76(02), e199–e206. https://doi.org/10.4088/jcp.14m09029

Brain Stimulation / Sep 01, 2014

Bilello, J. A., Thurmond, L. M., Vaishnavi, S., & Kinback, K. M. (2014). MDDScore and Biomarker Profiling in Patients Treated with Transcranial Magnetic Stimulation: Preliminary Data. Brain Stimulation, 7(5), e17. https://doi.org/10.1016/j.brs.2014.07.002

Comprehensive Psychiatry / Jan 01, 2013

Smith, K. M., Renshaw, P. F., & Bilello, J. (2013). The diagnosis of depression: current and emerging methods. Comprehensive Psychiatry, 54(1), 1–6. https://doi.org/10.1016/j.comppsych.2012.06.006

AIDS / Feb 01, 2001

Bilello, J., Belay, S., & Weislow, O. S. (2001). Development of novel approaches to the evaluation of virucidal agents: separation of treated virions from test compounds. AIDS, 15, S39. https://doi.org/10.1097/00002030-200102001-00056

Antimicrobial Agents and Chemotherapy / Apr 01, 2000

Snyder, S., D’Argenio, D. Z., Weislow, O., Bilello, J. A., & Drusano, G. L. (2000). The Triple Combination Indinavir-Zidovudine-Lamivudine Is Highly Synergistic. Antimicrobial Agents and Chemotherapy, 44(4), 1051–1058. https://doi.org/10.1128/aac.44.4.1051-1058.2000

AIDS / May 01, 1996

Stein, D. S., Fish, D. G., Bilello, J. A., Preston, S. L., Martineau, G. L., & Drusano, G. L. (1996). A 24-week open-label Phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir). AIDS, 10(5), 485–492. https://doi.org/10.1097/00002030-199605000-00006

Journal of Infectious Diseases / Mar 01, 1995

Bilello, J. A., Bilello, P. A., Prichard, M., Robins, T., & Drusano, G. L. (1995). Reduction Of The In Vitro Activity Of A77003, An Inhibitor Of Human Immunodeficiency Virus Protease, By Human Serum  1 Acid Glycoprotein. Journal of Infectious Diseases, 171(3), 546–551. https://doi.org/10.1093/infdis/171.3.546

Antiviral Research / Apr 01, 1991

Bilello, J. A., Dudley, M. N., & Drusano, G. L. (1991). In vitro pharmacodynamic modeling of anti-retroviral agents and interferon. Antiviral Research, 15, 151. https://doi.org/10.1016/0166-3542(91)90290-8

Immunology Letters / Feb 01, 1991

Martin, S. J., O’Neill, T. P., Bilello, J. A., & Eiseman, J. L. (1991). Lymphocyte transformation abnormalities in bovine immunodeficiency-like virus infected calves. Immunology Letters, 27(2), 81–84. https://doi.org/10.1016/0165-2478(91)90132-t

Biochemical and Biophysical Research Communications / Oct 01, 1986

Bilello, J. A., Hoffman, P. M., & Max, S. R. (1986). Altered cellular functions in a PC-12 cell clone chronically infected with retrovirus. Biochemical and Biophysical Research Communications, 140(2), 706–714. https://doi.org/10.1016/0006-291x(86)90789-8

Bioscience Reports / Aug 01, 1982

Siegler, E., Schaefer, A., & Bilello, J. A. (1982). Interferon-induced alterations in membrane functions and the growth of Daudi lymphoma and Friend leukemia cells. Bioscience Reports, 2(8), 605–608. https://doi.org/10.1007/bf01314223

Protein Biosynthesis in Eukaryotes / Jan 01, 1982

Koch, G., Koch, F., Bilello, J. A., Hiller, E., Schârli, C., Warnecke, G., & Weber, C. (1982). Biosynthesis, Modification and Processing of Viral Polyproteins. In Protein Biosynthesis in Eukaryotes (pp. 275–309). Springer US. https://doi.org/10.1007/978-1-4684-4124-6_12

Biosynthesis, Modification, and Processing of Cellular and Viral Polyproteins / Jan 01, 1980

Bilello, J. A., Warnecke, G., Weber, C., & Koch, G. (1980). ALTERATIONS IN THE PROCESSING AND SHEDDING OF RETROVIRUS PROTEINS IN FRIEND ERYTHROLEUKEMIA CELLS. In Biosynthesis, Modification, and Processing of Cellular and Viral Polyproteins (pp. 185–201). Elsevier. https://doi.org/10.1016/b978-0-12-417560-0.50021-0

Animal Virus Genetics / Jan 01, 1980

Frisby, D., Colletta, G., Pragnell, I., Ostertag, W., Bilello, J., Warnecke, G., & Koch, G. (1980). SFFV SPECIFIC GENE EXPRESSION IN INFECTED AND ERYTHROLEUKEMIA CELLS. In Animal Virus Genetics (pp. 411–423). Elsevier. https://doi.org/10.1016/b978-0-12-255850-4.50041-x

JNCI: Journal of the National Cancer Institute / Jun 01, 1977

Bilello, J. A., Freedman, V. H., & Shin, S. (1977). Growth of Murine Sarcoma Virus-Transformed Rat Kidney Cells in Nude Mice: Absence of Induction of Host Endogenous Viruses 2. JNCI: Journal of the National Cancer Institute, 58(6), 1691–1694. https://doi.org/10.1093/jnci/58.6.1691

Postgraduate Medicine / Dec 17, 2016

Bilello, J. A., & Tennant, F. S. (2016). Patterns of chronic inflammation in extensively treated patients with arachnoiditis and chronic intractable pain. Postgraduate Medicine, 129(1), 87–91. https://doi.org/10.1080/00325481.2017.1270155

Biomarkers in Medicine / Aug 01, 2016

Bilello, J. A. (2016). Seeking an objective diagnosis of depression. Biomarkers in Medicine, 10(8), 861–875. https://doi.org/10.2217/bmm-2016-0076

Molecular Psychiatry / Dec 08, 2015

Fava, M., Johe, K., Ereshefsky, L., Gertsik, L. G., English, B. A., Bilello, J. A., Thurmond, L. M., Johnstone, J., Dickerson, B. C., Makris, N., Hoeppner, B. B., Flynn, M., Mischoulon, D., Kinrys, G., & Freeman, M. P. (2015). A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Molecular Psychiatry, 21(10), 1372–1380. https://doi.org/10.1038/mp.2015.178

Molecular Psychiatry / Dec 13, 2011

Papakostas, G. I., Shelton, R. C., Kinrys, G., Henry, M. E., Bakow, B. R., Lipkin, S. H., Pi, B., Thurmond, L., & Bilello, J. A. (2011). Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study. Molecular Psychiatry, 18(3), 332–339. https://doi.org/10.1038/mp.2011.166

Cephalalgia / Aug 01, 2009

Ashina, M., Tvedskov, J., Lipka, K., Bilello, J., Penkowa, M., & Olesen, J. (2009). Matrix metalloproteinases during and outside of migraine attacks without aura. Cephalalgia, 30(3), 303–310. https://doi.org/10.1111/j.1468-2982.2009.01954.x

Thorax / Feb 27, 2007

Pinto-Plata, V., Toso, J., Lee, K., Park, D., Bilello, J., Mullerova, H., De Souza, M. M., Vessey, R., & Celli, B. (2007). Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax, 62(7), 595–601. https://doi.org/10.1136/thx.2006.064428

Proceedings of the American Thoracic Society / Aug 01, 2006

Pinto-Plata, V. (2006). Use of Proteomic Patterns of Serum Biomarkers in Patients with Chronic Obstructive Pulmonary Disease: Correlation with Clinical Parameters. Proceedings of the American Thoracic Society, 3(6), 465–466. https://doi.org/10.1513/pats.200603-030ms

Current Molecular Medicine / Feb 01, 2005

Bilello, J. (2005). The Agony and Ecstasy of “OMIC” Technologies in Drug Development. Current Molecular Medicine, 5(1), 39–52. https://doi.org/10.2174/1566524053152898

Antimicrobial Agents and Chemotherapy / Nov 01, 2003

Preston, S. L., Piliero, P. J., Bilello, J. A., Stein, D. S., Symonds, W. T., & Drusano, G. L. (2003). In Vitro-In Vivo Model for Evaluating the Antiviral Activity of Amprenavir in Combination with Ritonavir Administered at 600 and 100 Milligrams, Respectively, Every 12 Hours. Antimicrobial Agents and Chemotherapy, 47(11), 3393–3399. https://doi.org/10.1128/aac.47.11.3393-3399.2003

Antimicrobial Agents and Chemotherapy / Feb 01, 2002

Drusano, G. L., Bilello, P. A., Symonds, W. T., Stein, D. S., McDowell, J., Bye, A., & Bilello, J. A. (2002). Pharmacodynamics of Abacavir in an In Vitro Hollow-Fiber Model System. Antimicrobial Agents and Chemotherapy, 46(2), 464–470. https://doi.org/10.1128/aac.46.2.464-470.2002

The Journal of Infectious Diseases / Apr 01, 2001

Drusano, G. L., Bilello, J. A., Preston, S. L., O’Mara, E., Kaul, S., Schnittman, S., & Echols, R. (2001). Hollow‐Fiber Unit Evaluation of a New Human Immunodeficiency Virus Type 1 Protease Inhibitor, BMS‐232632, for Determination of the Linked Pharmacodynamic Variable. The Journal of Infectious Diseases, 183(7), 1126–1129. https://doi.org/10.1086/319281

Antimicrobial Agents and Chemotherapy / Jun 01, 2000

Drusano, G. L., D’Argenio, D. Z., Preston, S. L., Barone, C., Symonds, W., LaFon, S., Rogers, M., Prince, W., Bye, A., & Bilello, J. A. (2000). Use of Drug Effect Interaction Modeling with Monte Carlo Simulation To Examine the Impact of Dosing Interval on the Projected Antiviral Activity of the Combination of Abacavir and Amprenavir. Antimicrobial Agents and Chemotherapy, 44(6), 1655–1659. https://doi.org/10.1128/aac.44.6.1655-1659.2000

The Journal of Infectious Diseases / Oct 01, 1999

Skowron, G., Stein, D., Drusano, G., Melbourne, K., Bilello, J., Mikolich, D., Rana, K., Agosti, J. M., Mongillo, A., Whitmore, J., & Gilbert, M. J. (1999). The Safety and Efficacy of Granulocyte‐Macrophage Colony‐Stimulating Factor (Sargramostim) Added to Indinavir‐ or Ritonavir‐Based Antiretroviral Therapy: A Randomized Double‐Blind, Placebo‐Controlled Trial. The Journal of Infectious Diseases, 180(4), 1064–1071. https://doi.org/10.1086/314981

Antimicrobial Agents and Chemotherapy / Sep 01, 1998

Drusano, G. L., D’Argenio, D. Z., Symonds, W., Bilello, P. A., McDowell, J., Sadler, B., Bye, A., & Bilello, J. A. (1998). Nucleoside Analog 1592U89 and Human Immunodeficiency Virus Protease Inhibitor 141W94 Are Synergistic In Vitro. Antimicrobial Agents and Chemotherapy, 42(9), 2153–2159. https://doi.org/10.1128/aac.42.9.2153

AIDS Research and Human Retroviruses / Mar 20, 1998

LANDAY, A. L., BETHEL, J., & SCHNITTMAN, S. (1998). Phenotypic Variability of Lymphocyte Populations in Peripheral Blood and Lymph Nodes from HIV-Infected Individuals and the Impact of Antiretroviral Therapy. AIDS Research and Human Retroviruses, 14(5), 445–451. https://doi.org/10.1089/aid.1998.14.445

Journal of Infectious Diseases / Aug 01, 1998

Drusano, G. L., Bilello, J. A., Stein, D. S., Nessly, M., Meibohm, A., Emini, E. A., Deutsch, P., Condra, J., Chodakewitz, J., & Holder, D. J. (1998). Factors Influencing the Emergence of Resistance to Indinavir: Role of Virologic, Immunologic, and Pharmacologic Variables. Journal of Infectious Diseases, 178(2), 360–367. https://doi.org/10.1086/515631

The Journal of Infectious Diseases / Nov 01, 1997

Stein, D. S., Lyles, R. H., Graham, N. M. H., Tassoni, C. J., Margolick, J. B., Phair, J. P., Rinaldo, C., Saah, R. D. A., & Bilello, J. (1997). Predicting Clinical Progression or Death in Subjects with Early‐Stage Human Immunodeficiency Virus (HIV) Infection: A Comparative Analysis of Quantification of HIV RNA, Soluble Tumor Necrosis Factor Type II Receptors, Neopterin, and $\beta _{2}$ -Microglobulin. The Journal of Infectious Diseases, 176(5), 1161–1167. https://doi.org/10.1086/514108

Journal of Infectious Diseases / Feb 01, 1996

Bilello, J. A., Stellrecht, K., Drusano, G. L., & Stein, D. S. (1996). Soluble Tumor Necrosis Factor-  Receptor Type II (sTNF RII) Correlates with Human Immunodeficiency Virus (HIV) RNA Copy Number in HIV-Infected Patients. Journal of Infectious Diseases, 173(2), 464–467. https://doi.org/10.1093/infdis/173.2.464

Journal of Infectious Diseases / Apr 01, 1996

Cohen, O. J., Pantaleo, G., Holodniy, M., Fox, C. H., Orenstein, J. M., Schnittman, S., Niu, M., Graziosi, C., Pavlakis, G. N., Lalezari, J., Bartlett, J. A., Steigbigel, R. T., Cohn, J., Novak, R., McMahon, D., Bilello, J., & Fauci, A. S. (1996). Antiretroviral Monotherapy in Early Stage Human Immunodeficiency Virus Disease Has No Detectable Effect on Virus Load in Peripheral Blood and Lymph Nodes. Journal of Infectious Diseases, 173(4), 849–856. https://doi.org/10.1093/infdis/173.4.849

Antimicrobial Agents and Chemotherapy / May 01, 1996

Drusano, G. L., Prichard, M., Bilello, P. A., & Bilello, J. A. (1996). Modeling combinations of antiretroviral agents in vitro with integration of pharmacokinetics: guidance in regimen choice for clinical trial evaluation. Antimicrobial Agents and Chemotherapy, 40(5), 1143–1147. https://doi.org/10.1128/aac.40.5.1143

Journal of Infectious Diseases / Jun 01, 1996

Bilello, J. A., & Drusano, G. L. (1996). Relevance of Plasma Protein Binding to Antiviral Activity and Clinical Efficacy of Inhibitors of Human Immunodeficiency Virus Protease. Journal of Infectious Diseases, 173(6), 1524–1525. https://doi.org/10.1093/infdis/173.6.1524

Antimicrobial Agents and Chemotherapy / Jun 01, 1996

Bilello, J. A., Bilello, P. A., Stellrecht, K., Leonard, J., Norbeck, D. W., Kempf, D. J., Robins, T., & Drusano, G. L. (1996). Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease. Antimicrobial Agents and Chemotherapy, 40(6), 1491–1497. https://doi.org/10.1128/aac.40.6.1491

Proceedings of the National Academy of Sciences / Jun 01, 1987

Hoffman, P. M., Rohwer, R. G., MacAuley, C., Bilello, J. A., Hartley, J. W., & Morse, H. C. (1987). Transmission in NFS/N mice of the heritable spongiform encephalopathy associated with the gray tremor mutation. Proceedings of the National Academy of Sciences, 84(11), 3866–3870. https://doi.org/10.1073/pnas.84.11.3866

Proceedings of the National Academy of Sciences / Aug 01, 1974

Bilello, J. A., Strand, M., & August, J. T. (1974). Murine Sarcoma Virus Gene Expression: Transformants Which Express Viral Envelope Glycoprotein In The Absence Of The Major Internal Protein And Infectious Particles. Proceedings of the National Academy of Sciences, 71(8), 3234–3238. https://doi.org/10.1073/pnas.71.8.3234